A detailed history of Wellington Management Group LLP transactions in Cor Medix Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 180,948 shares of CRMD stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
180,948
Previous 78,421 130.74%
Holding current value
$1.87 Million
Previous $339,000 331.27%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.64 - $8.23 $373,198 - $843,797
102,527 Added 130.74%
180,948 $1.46 Million
Q2 2024

Aug 13, 2024

BUY
$4.08 - $6.39 $319,957 - $501,110
78,421 New
78,421 $339,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $426M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.